Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.

Also called NCT06869811

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 380 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06869811
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06869811. Randomized; single masking; primary purpose treatment. Start 2024-07-22 (actual); primary completion 2027-02-22 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral
Acronym
ADDLAAO
Condition
Left Atrial Appendage Closure
Intervention (Device)
LAA Closurse
Lead sponsor
Hospital Clinic of Barcelona (class: other)
Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (class: other)
Collaborator
Hospital San Carlos, Madrid (class: other)
Collaborator
Hospital Álvaro Cunqueiro (class: other)
Collaborator
Hospital Universitari de Bellvitge (class: other)
Collaborator
University of Salamanca (class: other)

Record details

Record id
cardio:ct-nct06869811
Content hash
4467fbe74595b6b033ac5c9ff6896cfabb5794bd3293aa4a897d0564028a2dec